Pulse Biosciences, Inc. PLSE Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -10,392.1%— | -21,982.6%— | -91,798.8%— | —— | —— | |
| Net margin | -9,929%— | -20,794.6%— | -86,898.8%— | —— | —— | |
| EBITDA margin | -10,252.7%— | -21,675.4%— | -90,516.3%— | —— | —— | |
| Free cash flow margin | -7,390%— | -15,553.4%— | -56,714%— | —— | —— | |
| Returns | ||||||
| Return on equity | -80.7%-2.9pp | -74.4%-7.1pp | -87%-16.7pp | -103.5%-2.8pp | -77.9%— | |
| Return on assets | -69.4%-3.4pp | -64.1%-8.2pp | -74.1%-16.0pp | -84.7%-8.2pp | -66%+5.3pp | |
| Return on invested capital | -1,211.5%-506pp | -1,168.1%-411pp | -1,141.3%-646pp | -914.4%-471pp | -705.7%-267pp | |
| Efficiency | ||||||
| Asset turnover | 0×— | 0×— | 0×— | 0×— | 0×— | |
| Inventory turnover | 7.7×— | —— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 7.3×-8.3× | 10.5×-1.4× | 10×-1.9× | 12×+7.5× | 15.6×+8.5× | |
| Quick ratio | 7.2×-8.3× | 10.5×-1.4× | 10×-1.9× | 12×+7.5× | 15.6×+8.5× | |
| Cash ratio | 7×-8.4× | 10.2×-1.5× | 9.8×-1.9× | 11.8×+7.5× | 15.4×+8.5× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.2× | 0.1×-0.2× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | 0.1×-0.1× | |
| Interest coverage | -22.1×-3.7× | -18.4×+2.6× | -18.6×+1.7× | -17.1×+4.8× | -18.4×+3.0× | |
| Valuation | ||||||
| Market capitalization | $1.47B+38.4% | $930.45M-13.1% | $1.19B+18.8% | $1.04B+67.8% | $1.06B+121% | |
| Enterprise value | $1.41B+48.1% | $857.24M-10.9% | $1.1B+18.4% | $937.91M+56.4% | $950.05M+109% | |
| Price / sales | 1,954.6×— | 2,658.4×— | 13,850.4×— | —— | —— | |
| Price / book | 22.1×+13.2× | 11.5×+2.2× | 12.9×+0.2× | 9.9×-13.0× | 9×-4.3× | |
| EV / sales | 1,873.1×— | 2,449.3×— | 12,835×— | —— | —— | |
| Free cash flow yield | -3.8%0.0pp | -5.9%-2.4pp | -4.1%-0.7pp | -4.3%+1.4pp | -3.8%+3.8pp | |
| Earnings yield | -5.1%+0.6pp | -7.8%-2.8pp | -6.3%-1.7pp | -6.6%+0.6pp | -5.7%+3.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Pulse Biosciences, Inc. (PLSE) runs a -4067.5% gross margin and a -10392.1% operating margin, with a -9929.0% net margin.
- Where do Pulse Biosciences, Inc.'s ratios come from?
- Every ratio is computed from Pulse Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
